Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Spatial activation of ezrin by epidermal growth factor receptor and focal adhesion kinase co-ordinates epithelial cell migration.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Chan GK;Chan GK; McGrath JA; McGrath JA; Parsons M; Parsons M
- Source:
Open biology [Open Biol] 2021 Aug; Vol. 11 (8), pp. 210166. Date of Electronic Publication: 2021 Aug 11.
- Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
- Language:
English
- Additional Information
- Source:
Publisher: Royal Society Pub Country of Publication: England NLM ID: 101580419 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2046-2441 (Electronic) Linking ISSN: 20462441 NLM ISO Abbreviation: Open Biol Subsets: MEDLINE
- Publication Information:
Original Publication: London : Royal Society Pub., [2011]-
- Subject Terms:
- Abstract:
Epidermal growth factor receptor (EGFR) plays a critical role in the promotion of epithelial cell proliferation and migration. Previous studies have suggested a cooperative role between EGFR and integrin signalling pathways that enable efficient adhesion and migration but the mechanisms controlling this remain poorly defined. Here, we show that EGFR forms a complex with focal adhesion kinase in epithelial cells. Surprisingly, this complex enhances local Src activity at focal adhesions to promote phosphorylation of the cytoskeletal adaptor protein ezrin at Y478, leading to actomyosin contractility, suppression of focal adhesion dynamics and slower migration. We further demonstrate this regulation of Src is due to the suppression of PTP1B activity. Our data provide new insight into EGF-independent cooperation between EGFR and integrins and suggest transient interactions between these kinases at the leading edge of cells act to spatially control signalling to permit efficient motility.
- References:
J Cell Sci. 1998 Mar;111 ( Pt 5):615-24. (PMID: 9454735)
Biochem Soc Trans. 2004 Jun;32(Pt3):438-42. (PMID: 15157155)
J Biol Chem. 2005 Sep 23;280(38):32856-65. (PMID: 16036919)
Oncotarget. 2017 Aug 7;8(41):70736-70751. (PMID: 29050315)
EMBO J. 1998 Nov 16;17(22):6622-32. (PMID: 9822606)
Am J Dermatopathol. 1996 Apr;18(2):165-71. (PMID: 8739992)
Mol Cell Biol. 2003 Nov;23(21):7875-86. (PMID: 14560030)
J Biol Chem. 2004 Apr 9;279(15):14551-60. (PMID: 14747473)
J Invest Dermatol. 2014 Oct;134(10):2570-2578. (PMID: 24691054)
J Invest Dermatol. 1984 Feb;82(2):165-9. (PMID: 6319502)
J Biol Chem. 2003 Jul 4;278(27):24865-73. (PMID: 12702722)
Nat Mater. 2017 Jul;16(7):775-781. (PMID: 28459445)
Nat Rev Mol Cell Biol. 2005 Jan;6(1):56-68. (PMID: 15688067)
Nature. 1995 Oct 12;377(6549):539-44. (PMID: 7566154)
Mol Cell Biol. 2004 Oct;24(19):8586-99. (PMID: 15367678)
J Biol Chem. 2001 Oct 5;276(40):37686-91. (PMID: 11468295)
Am J Pathol. 2008 Jul;173(1):14-24. (PMID: 18556782)
Nat Cell Biol. 2007 Sep;9(9):1046-56. (PMID: 17721515)
J Cell Sci. 2000 Jun;113 ( Pt 12):2139-47. (PMID: 10825287)
J Cell Biol. 2007 Feb 26;176(5):667-80. (PMID: 17325207)
Dev Cell. 2016 Aug 22;38(4):371-83. (PMID: 27554857)
J Biol Chem. 2000 Feb 25;275(8):5748-53. (PMID: 10681561)
J Cell Sci. 2018 Jul 4;131(13):. (PMID: 29777033)
J Clin Invest. 1994 Jul;94(1):68-78. (PMID: 8040293)
J Biol Chem. 2000 Aug 11;275(32):24565-74. (PMID: 10835423)
Mol Biol Cell. 1999 Sep;10(9):2861-78. (PMID: 10473632)
Nat Cell Biol. 2000 May;2(5):249-56. (PMID: 10806474)
Mol Cell Biol. 1999 Apr;19(4):3205-15. (PMID: 10082587)
J Clin Invest. 1997 Sep 1;100(5):1271-81. (PMID: 9276746)
Science. 1989 Feb 10;243(4892):811-4. (PMID: 2916128)
Oncoscience. 2018 Feb 23;5(1-2):21-38. (PMID: 29556515)
PLoS One. 2016 Mar 10;11(3):e0150567. (PMID: 26962872)
Nat Cell Biol. 2014 May;16(5):457-68. (PMID: 24747441)
J Biol Chem. 2002 Mar 15;277(11):9405-14. (PMID: 11756413)
Cancer Res. 1986 Jan;46(1):414-6. (PMID: 2998610)
Nat Cell Biol. 2004 Feb;6(2):154-61. (PMID: 14743221)
Oncol Lett. 2017 Feb;13(2):930-936. (PMID: 28356980)
J Biol Chem. 2005 Mar 18;280(11):10244-52. (PMID: 15623525)
J Invest Dermatol. 2004 Nov;123(5):982-9. (PMID: 15482488)
J Cell Sci. 2011 Jun 1;124(Pt 11):1808-18. (PMID: 21540295)
J Invest Dermatol. 1997 Dec;109(6):751-6. (PMID: 9406816)
Microsc Res Tech. 1998 Dec 1;43(5):444-55. (PMID: 9858341)
Oncogene. 2006 Feb 16;25(7):1081-9. (PMID: 16247468)
J Biol Chem. 2003 Oct 24;278(43):41677-84. (PMID: 12923167)
J Biomed Sci. 2016 Mar 17;23:35. (PMID: 26983550)
Nature. 1987 Aug 27-Sep 2;328(6133):817-20. (PMID: 2442615)
Oncogene. 2011 Sep 29;30(39):4087-96. (PMID: 21478906)
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14821-6. (PMID: 9843973)
J Invest Dermatol. 2008 Jun;128(6):1365-74. (PMID: 18049451)
- Contributed Indexing:
Keywords: EGFR; FAK; epithelial cell; ezrin; focal adhesion
- Accession Number:
0 (Cytoskeletal Proteins)
0 (ezrin)
EC 2.7.10.1 (EGFR protein, human)
EC 2.7.10.1 (ErbB Receptors)
EC 2.7.10.2 (Focal Adhesion Protein-Tyrosine Kinases)
- Publication Date:
Date Created: 20210810 Date Completed: 20220307 Latest Revision: 20220307
- Publication Date:
20240829
- Accession Number:
PMC8354753
- Accession Number:
10.1098/rsob.210166
- Accession Number:
34375550
No Comments.